Cyclosporine-related hemolytic-uremic syndrome in kidney graft recipients: clinical and histomorphologic evaluation.
Bren
A F
AF
Department of Nephrology, University Medical Center, Ljubljana, Slovenia.
Kandus
A
A
Buturovic
J
J
Koselj
M
M
Kaplan Pavlovcic
S
S
Ponikvar
R
R
Kovac
D
D
Lindic
J
J
Vizjak
A
A
Ferluga
D
D
D000328:Adult; D002102:Cadaver; D002648:Child; D016572:Cyclosporine / Q000009:adverse effects*; D005260:Female; D006463:Hemolytic-Uremic Syndrome / Q000139:chemically induced* / Q000453:epidemiology; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects* / Q000627:therapeutic use; D016030:Kidney Transplantation / Q000276:immunology* / Q000473:pathology; D019520:Living Donors; D008297:Male; D008775:Methylprednisolone / Q000627:therapeutic use; D008875:Middle Aged; D012189:Retrospective Studies; D013997:Time Factors; D014019:Tissue Donors
D007166:Immunosuppressive Agents; D016572:Cyclosporine; D008775:Methylprednisolone